Atypical Fibroxanthoma Treatment & Management

1. Kolb L, Schmieder GJ. Atypical Fibroxanthoma. StatPearls [Internet]. 2020 Jan. [Medline]. [Full Text].

2. Hussein MR. Atypical fibroxanthoma: new insights. Expert Rev Anticancer Ther. 2014 Sep. 14(9):1075-88. [Medline].

3. Diaz-Cascajo C, Borghi S, Bonczkowitz M. Pigmented atypical fibroxanthoma. Histopathology. 1998 Dec. 33(6):537-41. [Medline].

4. Requena L, Sangueza OP, Sanchez Yus E, Furio V. Clear-cell atypical fibroxanthoma: an uncommon histopathologic variant of atypical fibroxanthoma. J Cutan Pathol. 1997 Mar. 24(3):176-82. [Medline].

5. Bedir R, Agirbas S, Sehitoglu I, Yurdakul C, Elmas O. Clear cell atypical fibroxantoma: a rare variant of atypical fibroxanthoma and review of the literature. J Clin Diagn Res. 2014 Jun. 8(6):FD09-11. [Medline]. [Full Text].

6. Nemejcová K, Dundr P. Granular cell variant of atypical fibroxanthoma. A case report. Cesk Patol. 2014 Winter. 50(1):34-37. [Medline].

7. Rudisaile SN, Hurt MA, Santa Cruz DJ. Granular cell atypical fibroxanthoma. J Cutan Pathol. 2005 Apr. 32(4):314-7. [Medline].

8. Starink TH, Hausman R, Van Delden L, Neering H. Atypical fibroxanthoma of the skin. Presentation of 5 cases and a review of the literature. Br J Dermatol. 1977 Aug. 97(2):167-77. [Medline].

9. Singh M, Mann R, Ilankovan V, Hussein K, D'arrigo C. Atypical Fibroxanthoma-A Retrospective Immunohistochemical Study of 42 Cases. J Oral Maxillofac Surg. 2012 Apr 9. [Medline].

10. Michie BA, Reid RP, Fallowfield ME. Aneuploidy in atypical fibroxanthoma: DNA content quantification of 10 cases by image analysis. J Cutan Pathol. 1994 Oct. 21(5):404-7. [Medline].

11. Worrell JT, Ansari MQ, Ansari SJ, Cockerell CJ. Atypical fibroxanthoma: DNA ploidy analysis of 14 cases with possible histogenetic implications. J Cutan Pathol. 1993 Jun. 20(3):211-5. [Medline].

12. Bugatti L, Filosa G. Dermatoscopic features of cutaneous atypical fibroxanthoma: three cases. Clin Exp Dermatol. 2009 Dec. 34(8):e898-900. [Medline].

13. Calonje E, Wadden C, Wilson-Jones E, Fletcher CD. Spindle-cell non-pleomorphic atypical fibroxanthoma: analysis of a series and delineation of a distinctive variant. Histopathology. 1993 Mar. 22(3):247-54. [Medline].

14. Giuffrida TJ, Kligora CJ, Goldstein GD. Localized cutaneous metastases from an atypical fibroxanthoma. Dermatol Surg. 2004 Dec. 30(12 Pt 2):1561-4. [Medline].

15. Grosso M, Lentini M, Carrozza G, Catalano A. Metastatic atypical fibroxanthoma of skin. Pathol Res Pract. 1987 Jun. 182(3):443-7. [Medline].

16. Polcz MM, Sebaratnam DF, Fernández-Peñas P. Atypical fibroxanthoma management: Recurrence, metastasis and disease-specific death. Australas J Dermatol. 2017 Aug 17. [Medline].

17. Zalla MJ, Randle HW, Brodland DG, et al. Mohs surgery vs wide excision for atypical fibroxanthoma: follow-up. Dermatol Surg. 1997 Dec. 23(12):1223-4. [Medline].

18. Ang GC, Roenigk RK, Otley CC, Kim Phillips P, Weaver AL. More than 2 decades of treating atypical fibroxanthoma at mayo clinic: what have we learned from 91 patients?. Dermatol Surg. 2009 May. 35(5):765-72. [Medline].

19. Fish FS. Soft tissue sarcomas in dermatology. Dermatol Surg. 1996 Mar. 22(3):268-73. [Medline].

20. Phelan PS, Rosman IS, Council ML. Atypical Fibroxanthoma: The Washington University Experience. Dermatol Surg. 2019 Dec. 45 (12):1450-1458. [Medline].

21. Dokic Y, Nguyen QL, Orengo I. Mohs micrographic surgery: a treatment method for many non-melanocytic skin cancers. Dermatol Online J. 2020 Apr 15. 26 (4):[Medline].

Forrest C Brown, MD Clinical Professor of Dermatology, University of Texas Southwestern Medical School; Section Chief, Department of Dermatology, Medical City Dallas Hospital

Disclosure: Nothing to disclose.

Richard P Vinson, MD Assistant Clinical Professor, Department of Dermatology, Texas Tech University Health Sciences Center, Paul L Foster School of Medicine; Consulting Staff, Mountain View Dermatology, PA

Richard P Vinson, MD is a member of the following medical societies: American Academy of Dermatology, Texas Medical Association, Association of Military Dermatologists, Texas Dermatological Society

Disclosure: Nothing to disclose.

Rosalie Elenitsas, MD Herman Beerman Professor of Dermatology, University of Pennsylvania School of Medicine; Director, Penn Cutaneous Pathology Services, Department of Dermatology, University of Pennsylvania Health System

Rosalie Elenitsas, MD is a member of the following medical societies: American Academy of Dermatology, American Medical Association, American Society of Dermatopathology, Pennsylvania Academy of Dermatology

Disclosure: Received royalty from Lippincott Williams Wilkins for textbook editor.

William D James, MD Paul R Gross Professor of Dermatology, Vice-Chairman, Residency Program Director, Department of Dermatology, University of Pennsylvania School of Medicine

William D James, MD is a member of the following medical societies: American Academy of Dermatology, Society for Investigative Dermatology

Disclosure: Received income in an amount equal to or greater than $250 from: Elsevier; WebMD.

Carrie L Kovarik, MD Assistant Professor of Dermatology, Dermatopathology, and Infectious Diseases, University of Pennsylvania School of Medicine

Carrie L Kovarik, MD is a member of the following medical societies: Alpha Omega Alpha

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article